Podocyte vascular endothelial growth factor (Vegf 164 ) overexpression causes severe nodular glomerulosclerosis in a mouse model of type 1 diabetes

Induction of Podocyte VEGF164 Overexpression at Different Stages of Development Causes Congenital Nephrosis or Steroid-Resistant Nephrotic Syndrome

(2010) Delma Veron et al.   AMERICAN JOURNAL OF PATHOLOGY

Pathologic Classification of Diabetic Nephropathy

(2010) T. W. C. Tervaert et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

Overexpression of VEGF-A in podocytes of adult mice causes glomerular disease

(2010) Delma Veron et al.   KIDNEY INTERNATIONAL

Semaphorin3a regulates endothelial cell number and podocyte differentiation during glomerular development

(2009) K. J. Reidy et al.   DEVELOPMENT

Mouse Models of Diabetic Nephropathy

(2009) F. C. Brosius et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

Major contribution of tubular secretion to creatinine clearance in mice

(2009) Christoph Eisner et al.   KIDNEY INTERNATIONAL

Molecular mechanisms of proteinuria in diabetes

(2008) Luigi Gnudi   BIOCHEMICAL SOCIETY TRANSACTIONS

Inducible Overexpression of sFlt-1 in Podocytes Ameliorates Glomerulopathy in Diabetic Mice

(2008) C.-H. Ku et al.   DIABETES

Advanced glycation end-products suppress neuropilin-1 expression in podocytes

(2008) Tzvetanka Bondeva et al.   KIDNEY INTERNATIONAL

VEGF Inhibition and Renal Thrombotic Microangiopathy

(2008) Vera Eremina et al.   NEW ENGLAND JOURNAL OF MEDICINE

Matrix metalloproteinases and their inhibitors in vascular remodeling and vascular disease

(2007) Joseph D. Raffetto et al.   BIOCHEMICAL PHARMACOLOGY

Semaphorin3a disrupts podocyte foot processes causing acute proteinuria

(2007) R. Tapia et al.   KIDNEY INTERNATIONAL